Current status of clinical development of interleukin-10

Current Opinion in Hematology

Volumn 3, Issue 3, 1996, Pages 203-208

  Geissler, Klaus ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR; COMPLEMENTARY DNA; CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN RECEPTOR; LIPOPOLYSACCHARIDE; RECOMBINANT INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOMONOCYTIC LEUKEMIA; ENTERITIS; ENTEROPATHY; HUMAN; IMMUNOREGULATION; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEPSIS; SIGNAL TRANSDUCTION; ULCERATIVE COLITIS;

EID: 0029908539     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-199603030-00007     Document Type: Review

References (55)

1. Fiorentino DF, Bond MW, Mosmann TR: Two types of mouse T helper cell IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989, 170:2081-2095.
2. Moore KW, Vieira P, Fiorentino DF, Trounstine ML, Khan TA, Mosmann TR: Homology of cytokine synthesis Inhibiting factor (IL-10) to the Epstein-Barr virus gene BCRF1. Science 1990, 248:1230-1234
3. Vieira P, de Waal-Malefyt R, Dang MW, Johnson KE, Kastelein R, Fiorentino DF, de Vries JE, Roncarolo MG, Mosmann TR, Moore KW: Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI. Proc Natl Acad Sci U S A 1991, 88:1172-1176.
4. Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR: Interleukin-10. Ann Rev Immunol 1993, 11:165-190.
5. Wanidworanun C, Strober W: Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis. J Immunol 1993, 12:6853-6861.
6. De Waal Malefyt R, Abrams J, Bennet B, Figdor C, de Vries J: IL-10 inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991, 174:1209-1220.
7. Tan JC, Indelicato SR, Narula SK, Zavodny PJ, Chou CC: Characterization of interleukin-10 receptors on human and mouse cells. J Biol Chem 1993, 28:21053-21059.
8. Carson WE, Lindemann MJ, Baiocchi R, Linett M, Tan JC, Chou CC, Narula S, Caligiun MA: The functlonal characterization of interleukln-10 receptor expression on human natural killer cells. Blood 1995, 85:3577-3583.
9. Geissler K, Öhler L, Reiter E, Kollars M, Gisslinger H, Angelberger P, Leimer M, Lechner K, Virgolini I: Interleukin-10 regulates function and survival of human eoslnophlls via specific binding sites [abstract]. Blood 1995, 86:506a.
10. Ho ASY, Uu Y, Khan TA, Hsu DH, Bazan JF: A receptor for interleukin 10 is related to interferon receptors. Proc Natl Acad Sci U S A 1993, 90:11267-11271.
11. Liu Y, Wei SHY, Ho ASY, de Waal Malefyt R, Moore KW: Expression cloning and characterization of a human IL-10 receptor. J Immunol 1994, 152:1821-1829.
12. Ho ASY, Wei SHY, Mui ALF, Miyajima A, Moore KW: Functional regions of the mouse interleukin-10 receptor cytoplasmic domain. Mol Cell Biol 1995, 15:5043-5053.
13. Geng Y, Gulbins E, Altman A, Lotz M: Monocyte deactivation by interleukin-10 via Inhibition of tyroslne kinase activity and the Ras signaling pathway. Proc Natl Acad Sci U S A 1994, 91:8602-8606.
14. Lehmann J, Seegert D, Strehlow I, Schindler C, Lohmann-Matthes ML, Decker T: IL-10-induced factors belonging to the p91 family of proteins bind to IFN-gamma-responsive promoter elements. J Immunol 1994, 153:165-172.
15. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A: IL-10 Inhibits cytokine production by activated macrophages. J Immunol 1991, 147:3815-3822.
16. De Waal Malefyt R, Haanen J, Spits H, Roncarolo MG, te Velde A, Figdor C, Johnson K, Kastelein R, Yssel H, de Vries JE: Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 1991, 174:915-924.
17. Gazzinelli RT, Oswald IP, James SL, Sher A: IL-10 Inhibits parasite killing and nitrogen oxide production by IFN-gamma activated macrophages. J Immunol 1992, 148:1792-1796.
18. Te Velde AA, de Waal Malefyt R, Huijbens RJF, de Vries JE, Figdor CG: IL-10 stimulates monocyte Fc gamma R surface expression and cytotoxic activity. J Immunol 1992, 149:4048-4052.
19. Reiter E, Öhler L, Agis H, Valent P, Jäger U, Lechner K, Geissler K: Differential effects of IL-4 and IL-10 on the expression of the c3bi receptor on human monocytes/macrophages [abstract]. Blood 1993, 84:31a.
20. Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, O'Garra A: IL-10 acts on the antigen-presenting cell to Inhibit cytokine production by Th1 cells. J Immunol 1991, 146:3444-3451.
21. D'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G: Interleukin-10 (IL-10) inhibits human lymphocyte interferon-gamma production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 1993, 178:1041-1048.
22. Taga K, Mostowski H, Tosato G: Human interteukin-10 can directly Inhibit T cell growth. Blood 1993, 81:2964-2971.
23. Wang P, Wu P, Anthes JC, Siegel MI, Egan RW, Billah MM: Interleukin-10 Inhibits Interleukin-8 production in human neutrophils. Blood 1994, 83:2678-2683.
24. Kasama T, Strieter RM, Lukacs NW, Burdick MD, Kunkel SL: Regulation of neutrophil-derived chemokine expression by IL-10. J Immunol 1994, 152:3559-3569.
25. Takanaski S, Nonaka R, Xing Z, O'Byrne P, Dolovich J, Jordana M: Interleukin 10 inhibits lipopolysaccharide-induced survival and cytokine production by human peripheral blood eoslnophils. J Exp Med 1994, 180:711-715.
26. Go NF, Castle BE, Barrett R, Kastlelein R, Dang W, Mosmann TR, Moore KW, Howard M: Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells. J Exp Med 1990, 172:1625-1631.
27. Rousset F, Garcia E, Defrance T, Péronne C, Vezzio N, Hsu DH, Kastelstein R, Moore KW, Banchereau J: Human and viral IL-10 are potent growth and differentiation factors for activated human B lymphocytes. Proc Natl Acad Sci U S A 1992, 89:1890-1893.
28. Ruckiger AC, Garrone P, Durand I, Galizzi JP, Banchereau J: Interleukin 10 (IL-10) upregulates functional high affinity IL-2 receptors on normal and leukemic B lymphocytes. J Exp Med 1993, 178:1473-1481.
29. Öhler L, Reiter E, Fritsch G, Greinix H, Lechner K, Geissler K: IL-10 inhibits proliferation of hemopoietic progenitor cells in vitro [abstract]. Blood 1994, 84:268a.
30. Weber-Nordt RM, Henschler R, Schott E, Wehinger J, Behringer D, Mertelsmann R, Finke J: IL-10 increases BCL-2 expression in primary human CD34+ hematopoietic progenitor cells derived from bone marrow or peripheral blood. Blood 1995, 86:149a.
31. Thompson-Snipes LA, Dhar V, Bond MW, Mosmann TR, Moore KW, Rennick DM: Interleukin 10: a novel stimulatory factor for mast cells and their progenitors. J Exp Med 1991, 173:507-510.
32. Howard M, O'Garra A: Biological properties of interleukin 10. Immunol Today 1992, 13:198-200.
33. Kühn R, Lohler J, Rennick D, Rajewsky K, Muller W: Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993, 75:263-274.
34. Mitsuyama K, Toyonaga A, Tanikawa K, Ishida H: Immunosuppressive • role of interleukin-10 inflammatory bowel disease [abstract]. Gastroenterology 1995, 108:877a. This in vitro study demonstrates a beneficial effect of exogenous interleukin-10 on production of proinflammatory cytokines in colonic tissue obtained from patients with ulcerative colitis and Crohn's disease.
35. Schreiber S, Reinking R, Panzer U, Raedler A: Immunoregulatory role of • interleukin 10 in patients with inflammatory bowel disease. Gastroenterology 1995, 108:1434-1444. In addition to demonstrating the downregulation of proinflammatory cytokines in inflammatory bowel disease mononuclear phagocytes by exogenous interleukin-10 in vitro, this paper shows for the first time that inhibition of cytokine synthesis can be achieved by treatment with a topical interleukin-10 enema
36. Wardle TD: Interleukin 10 inhibits inflammatory mediator production in ulcerative colitis [abstract]. Gut 1994, 35:S48.
37. Koppen T, Nielsen OH, Eriksen J, Kirman I, et al.: Involvement of interleukin-10 (IL-10) in inflammatory bowel disease (IBD) [abstract]. Gastroenterology 1995, 108:851a.
38. Madsen KL, Tavemini MM, Federak RN: Interleukin-10 stimulates ion • absorption in mammalian small intestine [abstract]. Gastroenterology 1995, 108:868a. This functional study using the small intestine of rats and rabbits shows an antidiarrheal effect of interleukin-10, further suggesting the use of interleukin-10 in inflammatory bowel disease.
39. De Beaux AC, Ross JA, Fearon KCH, Carter DC: Down-regulation of interleukin (IL)-8 production from peripheral blood mononuclear cells from patients with acute pancreatitis by IL-4 and IL-10 [abstract]. Gut 1994, 35:S45.
40. Van Laethem JL, Marchant A, Delvaux A, Deviere J, et al.: Interleukin-10 •• (IL-10) decreases severity of acute necrotizing pancreatitis in mice [abstract]. Gastroenterology 1995, 108:397a. In this preclinical model a beneficial effect of interleukin-10 on necrotizing acute pancreatitis induced in mice by cerulein is shown and thus provides an important basis for interleukin-10 therapy of acute pancreatitis in humans.
41. Standiford TJ, Strieter RM, Lukacs NW, Kunkel SL: Neutralization of IL-10 Increases lethality in endotoxemia: cooperative effects of macrophage inflammatory protein-2 and tumor necrosis factor. J Immunol 1995, 155:2222-2229.
42. Knolle P, Schlaak J, Uhring A, Kempf P, Meyer zum Büschenfelde KH, Gerken G: Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS) challenge. J Hepatol 1995, 22:226-229.
43. Pradier O, Gerard C, Delvaux A, Capel P: Interleukin-10 inhibits procoagulant activity related to tissue factor expression induced by LPS on monocytes [abstract]. Blood 1993, 82:343a.
44. Howard M, Muchamel T, Andrade S, Menon S: Interleukin-10 protects mice from lethal endotoxemia. J Exp Med 1993, 177:1205-1208.
45. Rogy MA, Auffenberg T, Espat NJ, Philip R, Remick D, Wollenberg GK, •• Copeland EM III, Moldawer LL: Human tumor necrosis factor receptor (p55) and interleukin 10 gene transfer in the mouse reduces mortality to lethal endotoxemia and also attenuates local inflammatory responses. J Exp Med 1995, 181:2289-2293. In this study, interleukin-10 delivered to mice by means of cationic liposome-mediated human gene transfer is shown to reduce mortality in these animals after challenge with endotoxins. It suggests for the first time gene transfer with cytokines as a promising option for the treatment of septic shock.
46. Benjamin D, Knobloch TJ, Dayton MA: Human B-cell interleukin-10: B-cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt's lymphoma constitutively secrete large quantities of interleukin-10. Blood 1992, 80:1289-1298.
47. Masood R, Zhang Y, Bond MW, Scadden DT, Moudgil T, Law RE, Kaplan MH, Jung B, Espina BM, Lunardi-Iskandar Y, Levine AM, Gill PS: interleukin-10 is an autocrine growth factor for acquired immunodeficiency syndrome-related B-cell lymphoma. Blood 1995, 85:3423-3430.
48. Lu ZY, Zhang XG, Rodriguez C, Wijdenes J, Gu ZJ, Morel-Fournier B, Harousseau JL, Bataille R, Rossi JF, Klein B: Interleukin-10 is a proliferation factor but not a differentiation factor for human myeloma cells. Blood 1995, 85:2521-2527.
49. Baiocchi RA, Ross ME, Tan JC, Chou CC, Sullivan L, Haldar S, Monne M, Seiden MV, Narula SK, Sklar J, Croce CM, Caligiuri MA: Lymphomagenesis in the SCID-hu mouse involves abundant production of human Interleukin-10. Blood 1995, 85:1063-1074.
50. Kim J, Modlin RL, Moy RL, Dubinett SM, McHugh T, Nickoloff BJ, Uyemura K: IL-10 production in cutaneous basal and squamous cell carcinomas. A mechanism for evading the local T cell Immune response. J Immunol 1995, 155:2240-2247.
51. Fluckiger AC, Durand I, Banchereau J: Interleukin 10 Induces apoptotic cell death of B-chronic lymphocytlc leukemia cells. J Exp Med 1994, 179:91-99.
52. Jurlander J, Lau CF, Tan J, Chou CC, Geisler CH, Narula SK, Baumann H, Caligiuri MA: Interleukin-10 (IL-10) is a survival factor for B cell chronic lymphocytic leukemia (B-CLL) [abstract]. Blood 1995, 86:346a.
53. Itoh K, Hirohata S: The role of IL-10 in human B cell activation, proliferation, and differentiation. J Immunol 1995, 154:4341-4350.
54. Geissler K, Öhler L, Reiter E, Kabrna E, Rogy M, Födinger M, Mannhalter • C, Jäger U, Lechner K: Inhibitory effect of interleukin-10 on the autonomous in vitro growth of chronic myelomonocytic leukemia cells [abstract]. Blood 1995, 86:664a. This paper suggests a novel concept of interrupting the autocrine growth mechanism in chronic myelomonocytic leukemia by in vitro studies.
55. Chemoff AE, Granowitz EV, Shapiro L, Vannier E, Lonnemann G, •• Angel JB, Kennedy JS, Rabson AR, Wolff SM, Dinarello CA: A randomized, controlled trial of IL-10 in humans. Inhibition of Inflammatory cytokine production and immune responses. J Immunol 1995, 154:5492. Reports the administration of interleukin-10 in humans for the first time and shows that interleukin-10 is safe, has inhibitory effects on T cells, and suppresses production of proinflammatory cytokines in vivo.